Citations to this article
Abstract
Authors
Patrick H. Lizotte, Elena V. Ivanova, Mark M. Awad, Robert E. Jones, Lauren Keogh, Hongye Liu, Ruben Dries, Christina Almonte, Grit S. Herter-Sprie, Abigail Santos, Nora B. Feeney, Cloud P. Paweletz, Meghana M. Kulkarni, Adam J. Bass, Anil K. Rustgi, Guo-Cheng Yuan, Donald W. Kufe, Pasi A. Jänne, Peter S. Hammerman, Lynette M. Sholl, F. Stephen Hodi, William G. Richards, Raphael Bueno, Jessie M. English, Mark A. Bittinger, Kwok-Kin Wong
Total citations by year
Citation information
Citations to this article (87)
| Title and authors | Publication | Year |
|---|---|---|
|
Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression
Turlej E, Domaradzka A, Radzka J, Drulis-Fajdasz D, Kulbacka J, Gizak A |
Cells | 2025 |
|
Recent advancements in lung cancer research: a narrative review
Tang FH, Wong HY, Tsang PS, Yau M, Tam SY, Law L, Yau K, Wong J, Farah FH, Wong J |
Translational Lung Cancer Research | 2025 |
|
The role of B cell immunity in lung adenocarcinoma.
Shu L, Tao T, Xiao D, Liu S, Tao Y |
Genes and immunity | 2025 |
|
Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI.
Messana G, Bortolotto C, Thulasi Seetha S, Marrocco A, Pairazzi C, Sanvito F, Brero F, Robustelli Test A, Cabini RF, Lascialfari A, Zacà D, Stella GM, Agustoni F, Saddi J, Filippi AR, Preda L |
European radiology | 2025 |
|
Targeting neutrophils for cancer therapy.
Kwak JW, Houghton AM |
Nature reviews. Drug discovery | 2025 |
|
Semi-automated approaches for interrogating spatial heterogeneity of tissue samples.
Navikas V, Kowal J, Rodriguez D, Rivest F, Brajkovic S, Cassano M, Dupouy D |
Scientific Reports | 2024 |
|
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?
Riondino S, Rosenfeld R, Formica V, Morelli C, Parisi G, Torino F, Mariotti S, Roselli M |
Cancers | 2024 |
|
Discrete-state models identify pathway specific B cell states across diseases and infections at single-cell resolution
Kassis G, Palshikar MG, Hilchey SP, Zand MS, Thakar J |
Journal of Theoretical Biology | 2024 |
|
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
Veith I, Nurmik M, Mencattini A, Damei I, Lansche C, Brosseau S, Gropplero G, Corgnac S, Filippi J, Poté N, Guenzi E, Chassac A, Mordant P, Tosello J, Sedlik C, Piaggio E, Girard N, Camonis J, Shirvani H, Mami-Chouaib F, Mechta-Grigoriou F, Descroix S, Martinelli E, Zalcman G, Parrini MC |
Cell reports. Medicine | 2024 |
|
Causal association between immune cells and lung cancer risk: a two-sample bidirectional Mendelian randomization analysis
Xu S, Fang H, Shen T, Zhou Y, Zhang D, Ke Y, Chen Z, Lu Z |
Frontiers in immunology | 2024 |
|
Oral administration of oligo fucoidan improves the survival rate, quality of life, and immunity in patients with lung cancer
Liu TC, Shih CJ, Chiou YL |
Food & Nutrition Research | 2024 |
|
CXCR1/2 antagonism inhibits neutrophil function and not recruitment in cancer
Kwak JW, Nguyen HQ, Camai A, Huffman GM, Mekvanich S, Kenney NN, Zhu X, Randolph TW, Houghton AM |
OncoImmunology | 2024 |
|
Prognostic and Predictive Biomarkers of Oligometastatic NSCLC: New Insights and Clinical Applications
Jongbloed M, Bortolot M, Wee L, Huijs JW, Bellezo M, Vaes RD, Aboubakar Nana F, Hartemink KJ, De Ruysscher DK, Hendriks LE |
JTO Clinical and Research Reports | 2024 |
|
Autoimmunity and Carcinogenesis: Their Relationship under the Umbrella of Autophagy
Műzes G, Sipos F |
Biomedicines | 2023 |
|
Prognostic association of immunoproteasome expression in solid tumours is governed by the immediate immune environment
Kumar R, Dhaka B, Sahoo S, Jolly MK, Sabarinathan R |
Molecular Oncology | 2023 |
|
Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices
Roque K, Ruiz R, Mas L, Pozza DH, Vancini M, Silva Júnior JA, de Mello RA |
Cancers | 2023 |
|
Tumor-Infiltrating Lymphocytes and Adoptive Cell Therapy: State of the Art in Colorectal, Breast and Lung Cancer
ZEMANEK T, NOVA Z, NICODEMOU A |
2023 | |
|
Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy
M Duijvenvoorde, S Derks, I Bahce, C Leemans, R Ven, M Fransen |
IBMS BoneKEy | 2022 |
|
Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures
I Wieleba, K Wojas-Krawczyk, P Krawczyk, J Milanowski |
International journal of molecular sciences | 2022 |
|
Combined Consideration of Tumor-Associated Immune Cell Density and Immune Checkpoint Expression in the Peritumoral Microenvironment for Prognostic Stratification of Non-Small-Cell Lung Cancer Patients
Y Yang, X Yang, Y Wang, J Xu, H Shen, H Gou, X Qin, G Jiang |
Frontiers in immunology | 2022 |
|
Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy
J Ramos-Paradas, D Gómez-Sánchez, A Rosado, A Ucero, I Ferrer, R García-Luján, J Zugazagoitia, N Carrizo, A Enguita, E Conde, E Garrido-Martin, L Paz-Ares |
Journal of Clinical Medicine | 2022 |
|
Immune cell infiltration pattern in non-small cell lung cancer PDX models is a model immanent feature and correlates with a distinct molecular and phenotypic make-up
Eva Oswald, Daniel Bug, Anne Grote, Kanstantsin Lashuk, Nassim Bouteldja, Dorothee Lenhard, Anne Löhr, Anke Behnke, Volker Knauff, Anna Edinger, Kerstin Klingner, Simone Gaedicke, Gabriele Niedermann, Dorit Merhof, Friedrich Feuerhake, Julia Schueler |
Journal for ImmunoTherapy of Cancer | 2022 |
|
Autoimmunity and Cancer—Two Sides of the Same Coin
Sakowska J, Arcimowicz Ł, Jankowiak M, Papak I, Markiewicz A, Dziubek K, Kurkowiak M, Kote S, Kaźmierczak-Siedlecka K, Połom K, Marek-Trzonkowska N, Trzonkowski P |
Frontiers in immunology | 2022 |
|
Single B Cell Gene Co-Expression Networks Implicated in Prognosis, Proliferation, and Therapeutic Responses in Non-Small Cell Lung Cancer Bulk Tumors.
Ye Q, Guo NL |
Cancers | 2022 |
|
Influence of chemoradiation on the immune microenvironment of cervical cancer patients.
Herter JM, Kiljan M, Kunze S, Reinscheid M, Ibruli O, Cai J, Niu L, Heßelmann I, Trommer M, Herter-Sprie GS, Köhler C, Marnitz S |
2022 | |
|
Advances in the Lung Cancer Immunotherapy Approaches.
Padinharayil H, Alappat RR, Joy LM, Anilkumar KV, Wilson CM, George A, Valsala Gopalakrishnan A, Madhyastha H, Ramesh T, Sathiyamoorthi E, Lee J, Ganesan R |
Human vaccines | 2022 |
|
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results
Bortolotto C, Stella GM, Messana G, Lo Tito A, Podrecca C, Nicora G, Bellazzi R, Gerbasi A, Agustoni F, Grimm R, Zacà D, Filippi AR, Bottinelli OM, Preda L |
Cancers | 2022 |
|
Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways
Soltis AR, Bateman NW, Liu J, Nguyen T, Franks TJ, Zhang X, Dalgard CL, Viollet C, Somiari S, Yan C, Zeman K, Skinner WJ, Lee JS, Pollard HB, Turner C, Petricoin EF, Meerzaman D, Conrads TP, Hu H, Shriver CD, Moskaluk CA, Browning RF Jr, Wilkerson MD |
Cell reports. Medicine | 2022 |
|
Inferencing Bulk Tumor and Single-Cell Multi-Omics Regulatory Networks for Discovery of Biomarkers and Therapeutic Targets
Ye Q, Guo NL |
Cells | 2022 |
|
Dynamic monitoring of PD-L1 and Ki67 in circulating tumor cells of metastatic non-small cell lung cancer patients treated with pembrolizumab.
Spiliotaki M, Neophytou CM, Vogazianos P, Stylianou I, Gregoriou G, Constantinou AI, Deltas C, Charalambous H |
Molecular Oncology | 2022 |
|
Two Complementarity Immunotherapeutics in Non-Small-Cell Lung Cancer Patients—Mechanism of Action and Future Concepts
K Wojas-Krawczyk, P Krawczyk, M Gil, M Strzemski |
Cancers | 2021 |
|
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses
C Cui, J Wang, E Fagerberg, PM Chen, KA Connolly, M Damo, JF Cheung, T Mao, AS Askari, S Chen, B Fitzgerald, GG Foster, SC Eisenbarth, H Zhao, J Craft, NS Joshi |
Cell | 2021 |
|
Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling
Q Hu, Y Hong, P Qi, G Lu, X Mai, S Xu, X He, Y Guo, L Gao, Z Jing, J Wang, T Cai, Y Zhang |
Nature Communications | 2021 |
|
B cells in lung cancer—not just a bystander cell: a literature review
TL Leong, VL Bryant |
Translational Lung Cancer Research | 2021 |
|
Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study
MM Awad, YL Bruchec, B Lu, J Ye, JA Miller, PH Lizotte, ME Cavanaugh, AJ Rode, CD Dumitru, A Spira |
Frontiers in Oncology | 2021 |
|
Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer
J Błach, K Wojas-Krawczyk, M Nicoś, P Krawczyk |
International journal of molecular sciences | 2021 |
|
Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer
LM Sholl |
Modern Pathology | 2021 |
|
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma
J Budczies, M Kirchner, K Kluck, D Kazdal, J Glade, M Allgäuer, M Kriegsmann, CP Heußel, FJ Herth, H Winter, M Meister, T Muley, T Goldmann, S Fröhling, M Wermke, CF Waller, A Tufman, M Reck, S Peters, P Schirmacher, M Thomas, P Christopoulos, A Stenzinger |
Cancer Immunology, Immunotherapy | 2021 |
|
Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy
K Wojas-Krawczyk, I Paśnik, T Kucharczyk, I Wieleba, N Krzyżanowska, M Gil, P Krawczyk, J Milanowski |
International journal of molecular sciences | 2021 |
|
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer.
Federico L, McGrail DJ, Bentebibel SE, Haymaker C, Ravelli A, Forget MA, Karpinets T, Jiang P, Reuben A, Negrao MV, Li J, Khairullah R, Zhang J, Weissferdt A, Vaporciyan AA, Antonoff MB, Walsh G, Lin SY, Futreal A, Wistuba I, Roth J, Byers LA, Gaudreau PO, Uraoka N, Cruz AF, Dejima H, Lazcano RN, Solis LM, Parra ER, Lee JJ, Swisher S, Cascone T, Heymach JV, Zhang J, Sepesi B, Gibbons DL, Bernatchez C |
2021 | |
|
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity
S Ackerman, C Pearson, J Gregorio, J Gonzalez, J Kenkel, F Hartmann, A Luo, P Ho, H LeBlanc, L Blum, S Kimmey, A Luo, M Nguyen, J Paik, L Sheu, B Ackerman, A Lee, H Li, J Melrose, R Laura, V Ramani, K Henning, D Jackson, B Safina, G Yonehiro, B Devens, Y Carmi, S Chapin, S Bendall, M Kowanetz, D Dornan, E Engleman, M Alonso |
2020 | |
|
Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer
T Geraghty, A Rajagopalan, R Aslam, A Pohlman, I Venkatesh, A Zloza, D Cimbaluk, DG DeNardo, V Gupta |
Frontiers in Oncology | 2020 |
|
Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?
M Gascón, D Isla, M Cruellas, EM Gálvez, R Lastra, M Ocáriz, JR Paño, A Ramírez, A Sesma, I Torres-Ramón, A Yubero, J Pardo, L Martínez-Lostao |
Cells | 2020 |
|
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer
R Li, H Zhang, Y Cao, X Liu, Y Chen, Y Qi, J Wang, K Yu, C Lin, H Liu, H He, H Li, L Chen, Z Shen, J Qin, W Zhang, Y Sun, J Xu |
Cancer Immunology, Immunotherapy | 2020 |
|
Imperfect Predictors for Lung Cancer Immunotherapy—A Field for Further Research
K Wojas-Krawczyk, T Kubiatowski |
Frontiers in Oncology | 2020 |
|
MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity
E Grunblatt, N Wu, H Zhang, X Liu, JP Norton, Y Ohol, P Leger, JB Hiatt, EC Eastwood, R Thomas, AH Ibrahim, D Jia, R Basom, KD Eaton, R Martins, AM Houghton, D MacPherson |
Genes & development | 2020 |
|
Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non–small-cell Lung Cancer
A Tøndell, SG Wahl, AM Sponaas, S Sørhaug, M Børset, M Haug |
Translational oncology | 2020 |
|
A 5-Gene Signature Is Closely Related to Tumor Immune Microenvironment and Predicts the Prognosis of Patients with Non-Small Cell Lung Cancer
J Li, H Wang, Z Li, C Zhang, C Zhang, C Li, H Yu, H Wang |
BioMed Research International | 2020 |
|
Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors
Y Yamamoto, K Iwahori, S Funaki, M Matsumoto, M Hirata, T Yoshida, R Kanzaki, T Kanou, N Ose, M Minami, E Sato, A Kumanogoh, Y Shintani, M Okumura, H Wada |
Scientific Reports | 2020 |
|
Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state
J Huang, J Li, S Zheng, Z Lu, Y Che, S Mao, Y Lei, R Zang, C Liu, X Wang, L Fang, N Sun, J He |
Cancer Science | 2020 |
|
Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer
J Sun, Z Zhang, S Bao, C Yan, P Hou, N Wu, J Su, L Xu, M Zhou |
Journal for ImmunoTherapy of Cancer | 2020 |
|
Immune Escape Mechanisms in Non Small Cell Lung Cancer
A Anichini, VE Perotti, F Sgambelluri, R Mortarini |
Cancers | 2020 |
|
Differential gene expression of tumor-infiltrating CD8 + T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis
R Saleh, VS Nair, SM Toor, RZ Taha, K Murshed, M Al-Dhaheri, M Khawar, MA Petkar, MA Nada, F Al-Ejeh, E Elkord |
Journal for ImmunoTherapy of Cancer | 2020 |
|
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC
Julia Kargl, Xiaodong Zhu, Huajia Zhang, grace hy yang, Travis J Friesen, melissa shipley, Dean Y. Maeda, John A. Zebala, Jill McKay-Fleisch, Gavin Meredith, Afshin Mashadi-Hossein, Christina Baik, Robert H. Pierce, Mary W Redman, Jeffrey C. Thompson, Steven M Albelda, Hamid Bolouri, A McGarry Houghton |
JCI Insight | 2019 |
|
Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment
K Iwahori, Y Shintani, S Funaki, Y Yamamoto, M Matsumoto, T Yoshida, A Morimoto-Okazawa, A Kawashima, E Sato, S Gottschalk, M Okumura, A Kumanogoh, H Wada |
Scientific Reports | 2019 |
|
Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer
SM O'Brien, A Klampatsa, JC Thompson, MC Martinez, WT Hwang, AS Rao, JE Standalick, S Kim, E Cantu, LA Litzky, S Singhal, EB Eruslanov, EK Moon, SM Albelda |
Cancer immunology research | 2019 |
|
Identification of 15 T Cell Restricted Genes Evaluates T Cell Infiltration of Human Healthy Tissues and Cancers and Shows Prognostic and Predictive Potential
Cari, D Rosa, Petrillo, Migliorati, Nocentini, Riccardi |
International journal of molecular sciences | 2019 |
|
Immune Cell Composition in Human Non-small Cell Lung Cancer
B Stankovic, HA Bjørhovde, R Skarshaug, H Aamodt, A Frafjord, E Müller, C Hammarström, K Beraki, ES Bækkevold, PR Woldbæk, Å Helland, OT Brustugun, I Øynebråten, A Corthay |
Frontiers in immunology | 2019 |
|
Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer
S Singhal, J Stadanlick, MJ Annunziata, AS Rao, PS Bhojnagarwala, S OBrien, EK Moon, E Cantu, G Danet-Desnoyers, HJ Ra, L Litzky, T Akimova, UH Beier, WW Hancock, SM Albelda, EB Eruslanov |
Science Translational Medicine | 2019 |
|
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients
F Passiglia, A Galvano, M Castiglia, L Incorvaia, V Calò, A Listì, S Mazzarisi, A Perez, G Gallina, S Rizzo, HS Parra, V Bazan, A Russo |
Therapeutic advances in medical oncology | 2019 |
|
Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile
RD Groot, MM Loenen, A Guislain, BP Nicolet, JJ Heeren, OJ Verhagen, MM Heuvel, JD Jong, P Burger, CE Schoot, RM Spaapen, D Amsen, JB Haanen, K Monkhorst, KJ Hartemink, MC Wolkers |
OncoImmunology | 2019 |
|
Tumor mutational burden in lung cancer: a systematic literature review
C Willis, M Fiander, D Tran, B Korytowsky, JM Thomas, F Calderon, TM Zyczynski, D Brixner, DD Stenehjem |
Oncotarget | 2019 |
|
Frameshift events predict anti-PD-1/L1 response in head and neck cancer
Glenn Hanna, Patrick Lizotte, Megan Cavanaugh, Frank C. Kuo, Priyanka Shivdasani, Alexander Frieden, Nicole Chau, Jonathan Schoenfeld, Jochen Lorch, Ravindra Uppaluri, Laura MacConaill, Robert Haddad |
JCI Insight | 2018 |
|
TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy
HENG-JIA LIU, Patrick Lizotte, Heng Du, Maria Speranza, Hilaire Lam, Spencer Vaughan, Nicola Alesi, Kwok-Kin Wong, Gordon Freeman, Arlene Sharpe, Elizabeth Petri Henske |
JCI Insight | 2018 |
|
TARGETING THE HUMAN MUC1-C ONCOPROTEIN WITH AN ANTIBODY-DRUG CONJUGATE
Govind Panchamoorthy, Caining Jin, Deepak Raina, Ajit Bharti, Masaaki Yamamoto, Dennis Adeegbe, Qing Zhao, Roderick T. Bronson, Shirley Jiang, Linjing Li, Yozo Suzuki, Ashujit Tagde, Paiman Ghoroghchian, Kwok-Kin Wong, Surender Kharbanda, Donald W Kufe |
JCI Insight | 2018 |
|
The lung microenvironment: an important regulator of tumour growth and metastasis
NK Altorki, GJ Markowitz, D Gao, JL Port, A Saxena, B Stiles, T McGraw, V Mittal |
Nature Reviews Cancer | 2018 |
|
Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer
N Borcherding, R Kolb, J Gullicksrud, P Vikas, Y Zhu, W Zhang |
Journal of Molecular Biology | 2018 |
|
A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing
PH Lizotte, RL Hong, TA Luster, ME Cavanaugh, LJ Taus, S Wang, A Dhaneshwar, N Mayman, A Yang, M Kulkarni, L Badalucco, E Fitzpatrick, HF Kao, M Kuraguchi, M Bittinger, PT Kirschmeier, NS Gray, DA Barbie, PA Jänne |
Cancer immunology research | 2018 |
|
Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations
MI Toki, N Mani, JW Smithy, Y Liu, M Altan, B Wasserman, R Tuktamyshov, K Schalper, KN Syrigos, DL Rimm |
Journal of Thoracic Oncology | 2018 |
|
Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy
O Hemminki, M Oksanen, K Taipale, I Liikanen, A Koski, T Joensuu, A Kanerva, A Hemminki |
Molecular Therapy — Oncolytics | 2018 |
|
The non-small cell lung cancer immune landscape: emerging complexity, prognostic relevance and prospective significance in the context of immunotherapy
A Anichini, E Tassi, G Grazia, R Mortarini |
Cancer Immunology, Immunotherapy | 2018 |
|
Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy
FS Varn, LJ Tafe, CI Amos, C Cheng |
OncoImmunology | 2018 |
|
Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
S Wang, W Liu, D Ly, H Xu, L Qu, L Zhang |
Cellular and Molecular Immunology | 2018 |
|
Mechanisms of tumor immunotherapy, with a focus on thoracic cancers
S Ferro, V Huber, L Rivoltini |
Journal of Thoracic Disease | 2018 |
|
Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer
M Albitar, S Sudarsanam, W Ma, S Jiang, W Chen, V Funari, F Blocker, S Agersborg |
Oncotarget | 2018 |
|
A B cell-derived gene expression signature associates with an immunologically active tumor microenvironment and response to immune checkpoint blockade therapy
FS Varn, Y Wang, C Cheng |
OncoImmunology | 2018 |
|
Common Mechanisms Linking Chronic Obstructive Pulmonary Disease and Lung Cancer
AM Houghton |
Annals of the American Thoracic Society | 2018 |
|
Non-invasive assessment of tumor PD-L1 status with circulating tumor cells
BC Ulrich, N Guibert |
Annals of translational medicine | 2018 |
|
Informatics for cancer immunotherapy
J Hammerbacher, A Snyder |
Annals of Oncology | 2017 |
|
Prospects for combined use of oncolytic viruses and CAR T-cells
A Ajina, J Maher |
Journal for ImmunoTherapy of Cancer | 2017 |
|
Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8 + T Cells
CD Zahm, VT Colluru, DG McNeel |
Cancer immunology research | 2017 |
|
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
RW Jenkins, AR Aref, PH Lizotte, E Ivanova, S Stinson, CW Zhou, M Bowden, J Deng, H Liu, D Miao, MX He, W Walker, G Zhang, T Tian, C Cheng, Z Wei, S Palakurthi, M Bittinger, H Vitzthum, JW Kim, A Merlino, M Quinn, C Venkataramani, JA Kaplan, A Portell, PC Gokhale, B Phillips, A Smart, A Rotem, RE Jones, L Keogh, M Anguiano, L Stapleton, Z Jia, M Barzily-Rokni, I Cañadas, TC Thai, MR Hammond, R Vlahos, ES Wang, H Zhang, S Li, GJ Hanna, W Huang, MP Hoang, A Piris, JP Eliane, AO Stemmer-Rachamimov, L Cameron, MJ Su, P Shah, B Izar, M Thakuria, NR LeBoeuf, G Rabinowits, V Gunda, S Parangi, JM Cleary, BC Miller, S Kitajima, R Thummalapalli, B Miao, TU Barbie, V Sivathanu, J Wong, WG Richards, R Bueno, CH Yoon, J Miret, M Herlyn, LA Garraway, EM van Allen, GJ Freeman, PT Kirschmeier, JH Lorch, PA Ott, FS Hodi, KT Flaherty, RD Kamm, GM Boland, KK Wong, D Dornan, CP Paweletz, DA Barbie |
Cancer Discovery | 2017 |
|
Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules
A Kawashima, T Kanazawa, K Goto, M Matsumoto, A Morimoto-Okazawa, K Iwahori, T Ujike, A Nagahara, K Fujita, M Uemura, N Nonomura, H Wada |
Cancer Immunology, Immunotherapy | 2017 |
|
Implications of the tumor immune microenvironment for staging and therapeutics
JM Taube, J Galon, LM Sholl, SJ Rodig, TR Cottrell, NA Giraldo, AS Baras, SS Patel, RA Anders, DL Rimm, A Cimino-Mathews |
Modern Pathology | 2017 |
|
Quantitative Mass Spectrometry Analysis of PD-L1 Protein Expression, N -glycosylation and Expression Stoichiometry with PD-1 and PD-L2 in Human Melanoma
CA Morales-Betanzos, H Lee, PI Ericsson, JM Balko, DB Johnson, LJ Zimmerman, DC Liebler |
Molecular & cellular proteomics : MCP | 2017 |
|
PD-L1 expression and CD8+ tumor-infiltrating lymphocytes are associated with ALK rearrangement and clinicopathological features in inflammatory myofibroblastic tumors
YJ Cha, HS Shim |
Oncotarget | 2017 |
|
The role of immune checkpoint inhibition in the treatment of ovarian cancer
SL Gaillard, AA Secord, B Monk |
Gynecologic Oncology Research and Practice | 2016 |
